Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

v3.22.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) - CAD ($)
Total
Share Purchase Agreement
At-the-market agreement
Public Offering
Share Capital
Share Capital
Share Purchase Agreement
Share Capital
At-the-market agreement
Share Capital
Public Offering
Warrants
Contributed Surplus
Accumulated Other Comprehensive Income
Accumulated Deficit
Equity balance at beginning of period at Dec. 31, 2018 $ 6,195,363       $ 285,193,061       $ 3,617,570 $ 28,260,613 $ 607,504 $ (311,483,385)
Net loss and other comprehensive income (33,266,291)                   (143,403) (33,122,888)
Issued pursuant to incentive share award plan (note 10) 0       391,917         (391,917)    
Issued   $ 5,403,385 $ 8,476,454 $ 3,314,429   $ 5,403,385 $ 8,476,454 $ 3,314,429        
Issued pursuant to warrant derivative exercised (note 8, 9) 9,152,869       9,152,869              
Share-based compensation (note 10) 1,470,153                 1,470,153    
Share issue costs (note 9) (854,256)       (854,256)              
Equity balance at end of period at Dec. 31, 2019 (107,894)       311,077,859       3,617,570 29,338,849 464,101 (344,606,273)
Net loss and other comprehensive income (22,568,933)                   (63,876) (22,505,057)
Issued pursuant to stock option plan (note 10) 241,922       385,022         (143,100)    
Issued pursuant to incentive share award plan (note 10) 0       732,367         (732,367)    
Issued     40,037,786       40,037,786          
Issued pursuant to warrant derivative exercised (note 8, 9) 6,332,778       6,332,778              
Share-based compensation (note 10) 2,558,974                 2,558,974    
Share issue costs (note 9) (1,741,640)       (1,741,640)              
Equity balance at end of period at Dec. 31, 2020 24,752,993       356,824,172       3,617,570 31,022,356 400,225 (367,111,330)
Net loss and other comprehensive income (26,316,766)                   (12,487) (26,304,279)
Issued pursuant to stock option plan (note 10) 238,450       381,771         (143,321)    
Issued pursuant to incentive share award plan (note 10) 0       543,833         (543,833)    
Issued     $ 34,168,071       $ 34,168,071          
Issued pursuant to warrant derivative exercised (note 8, 9) 686,616       686,616              
Share-based compensation (note 10) 3,825,901                 3,825,901    
Share issue costs (note 9) (1,256,280)       (1,256,280)              
Equity balance at end of period at Dec. 31, 2021 $ 36,098,985       $ 391,348,183       $ 3,617,570 $ 34,161,103 $ 387,738 $ (393,415,609)